Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$29.79 USD
+0.79 (2.72%)
Updated May 3, 2024 04:00 PM ET
After-Market: $29.77 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -1.00 |
EPS Last Quarter | -0.97 |
Last EPS Surprise | -29.33% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.44 |
Next Year | -5.12 |
EPS (TTM) | -3.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.00 | -1.05 | -4.44 | -5.12 |
# of Estimates | 6 | 6 | 8 | 6 |
Most Recent Consensus | -0.76 | -1.12 | -4.77 | -5.32 |
High Estimate | -0.76 | -0.81 | -3.24 | -4.33 |
Low Estimate | -1.22 | -1.27 | -5.34 | -6.02 |
Year ago EPS | -1.20 | -0.74 | -3.42 | -4.44 |
Year over Year Growth Est. | 16.67% | -41.89% | -29.82% | -15.24% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 4 | 4 | 7 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.00 | -1.05 | -4.44 | -5.12 |
7 Days Ago | -1.00 | -1.05 | -4.44 | -5.12 |
30 Days Ago | -1.00 | -1.05 | -4.44 | -5.05 |
60 Days Ago | -0.87 | -0.89 | -3.78 | -4.57 |
90 Days Ago | -0.87 | -0.87 | -3.77 | -4.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.00 | -1.05 | -4.44 | -5.19 |
Zacks Consensus Estimate | -1.00 | -1.05 | -4.44 | -5.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -1.43% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.97 | -0.58 | -0.74 | -1.20 | NA |
Estimate | -0.75 | -0.75 | -0.88 | -0.62 | NA |
Difference | -0.22 | 0.17 | 0.14 | -0.58 | -0.12 |
Surprise | -29.33% | 22.67% | 15.91% | -93.55% | -21.08% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more